ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| PegBio Co., Ltd. | 2565 | Hong Kong | — | 85 |
| ImmuneOncia Therapeutics, Inc. | 424870 | South Korea | — | 84 |
| Microlin Bio, Inc Delisted | — | United States of America | — | 84 |
| ARONEX PHARMACEUTICALS INC Delisted | — | United States of America | — | 83 |
| Cellbion Co., Ltd | 308430 | South Korea | — | 83 |
| CAMBRIDGE NEUROSCIENCE INC Delisted | — | United States of America | — | 82 |
| LIPOSOME CO INC Delisted | — | United States of America | — | 82 |
| ARMO BIOSCIENCES INC. Delisted | ARMO | United States of America | — | 81 |
| Cocensys Inc Delisted | COCN | United States of America | — | 81 |
| ImmunoClin Corporation Delisted | IMCL | United States of America | — | 79 |
| Shine-On BioMedical Co., Ltd. | 6926 | Taiwan | — | 79 |
| Exscientia plc Delisted | — | United Kingdom | — | 78 |
| イノバセル株式会社 | 504A | Japan | — | 78 |
| First Tracks Biotherapeutics, Inc. | TRAX | United States of America | — | 77 |
| ORGANOIDSCIENCES LTD. | 476040 | South Korea | — | 77 |
| Pentixapharm Holding AG | PTP | Germany | — | 77 |
| Vilacto Bio Inc. Delisted | — | United States of America | — | 77 |
| SpyGlass Pharma, Inc. | SGP | United States of America | — | 76 |
| CREATIVE BIOMOLECULES INC Delisted | — | United States of America | — | 75 |
| COULTER PHARMACEUTICALS INC Delisted | — | United States of America | — | 74 |
| Psych Capital Plc | PSY | United Kingdom | — | 74 |
| IMMULOGIC PHARMACEUTICAL CORP Delisted | — | United States of America | — | 73 |
| Macrocure Ltd Delisted | MCUR | United States of America | — | 73 |
| Suzhou Ribo Life Science Co., Ltd. | 6938 | Hong Kong | — | 73 |
| ANTEX BIOLOGICS INC Delisted | — | United States of America | — | 72 |
| COLLATERAL THERAPEUTICS INC Delisted | — | United States of America | — | 72 |
| Guangzhou Innogen Pharmaceutical Group Co., Ltd. | 2591 | Hong Kong | — | 72 |
| Aktis Oncology, Inc. | AKTS | United States of America | — | 71 |
| Definium Therapeutics, Inc. | DFTX | Canada | — | 71 |
| Epi Biotech Co., Ltd. | 446440 | South Korea | — | 71 |
| PACIFIC PHARMACEUTICALS INC Delisted | — | United States of America | — | 71 |
| Deutsche Biotech Innovativ AG | DBI | Germany | — | 70 |
| FERMAVIR PHARMACEUTICALS, INC. Delisted | — | United States of America | — | 70 |
| Ambrx Biopharma, Inc. Delisted | — | United States of America | — | 69 |
| 3 DIMENSIONAL PHARMACEUTICALS INC Delisted | — | United States of America | — | 67 |
| Lophos Holdings Inc. | MESC | Canada | — | 67 |
| Odyssey Therapeutics, Inc. | ODTX | United States of America | — | 67 |
| SPIROS DEVELOPMENT CORP II INC Delisted | — | United States of America | — | 67 |
| China Bio-Immunity CORP Delisted | — | United States of America | — | 66 |
| THERAPEUTIC ANTIBODIES INC Delisted | — | United States of America | — | 66 |
| AnnJi Pharmaceutical Co., Ltd. | 7754 | Taiwan | — | 65 |
| J-Pharma Co.,Ltd. | 520A | Japan | — | 65 |
| Kailera Therapeutics, Inc. | KLRA | United States of America | — | 65 |
| NORTH AMERICAN VACCINE INC Delisted | — | United States of America | — | 65 |
| AV Therapeutics, Inc. Delisted | — | United States of America | — | 63 |
| SIBIA NEUROSCIENCES INC Delisted | — | United States of America | — | 63 |
| LXR BIOTECHNOLOGY INC Delisted | — | United States of America | — | 62 |
| B&K CORPORATION LIMITED | 2396 | Hong Kong | — | 61 |
| LEUKOSITE INC Delisted | — | United States of America | — | 60 |
| U S BIOSCIENCE INC Delisted | — | United States of America | — | 60 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.